MedTrace Logo

HIP Fracture REhabilitation Programme for Elderly With Hip Fractures

NCT03828240 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2019-09-06

No results posted yet for this study

Summary

Objectives: To evaluate the feasibility of a HIP fracture REhabilitation Programme (HIP-REP).This study will investigate adherence, satisfaction, technical and practical circumstances regarding implementation and taking this into account when evaluating the feasibility of the HIP-REP program.

Hypothesis: By testing the feasibility of a HIP-REP for the participants and the usefulness of the selected measurement tools, the investigators will be able to evaluate and adjust the HIP-REP before evaluating this in a larger Randomized controlled trial (RCT).

Conditions

  • Hip Fractures

Interventions

OTHER

HIP fracture REhabilitation Programme for the elderly with hip fractures

Eight-week activity-based intervention for elderly with hip fractures; one intervention during the hospital stay, four interventions at the elderly's municipality.

Sponsors & Collaborators

  • Municipality of Herlev

    collaborator UNKNOWN

  • Municipality of Lyngby-Taarbæk

    collaborator UNKNOWN

  • Municipality of Gentofte

    collaborator UNKNOWN

  • Copenhagen University Hospital at Herlev

    collaborator OTHER

  • Jonkoping University

    collaborator OTHER

  • Intersectoral Research Unit

    collaborator UNKNOWN

  • Metropolitan University College

    collaborator OTHER

  • Danish Association of Occupational Therapist

    collaborator OTHER

  • Danish Regions Development and Research

    collaborator UNKNOWN

  • Herlev and Gentofte Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2019-07-01
Completion
2019-07-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03828240 on ClinicalTrials.gov